R esidual white cells (WBCs) in blood components are lhe cause of a number of deleterious effects in blood transfusion practice: febrile nonhemolytic transfusion reactions, alloimmunization, transmission of infectious agents such as cytomegalovirus and human T-lymphotropic vírus, graft-versus-host disease, and immunomodulation.1-3 Furthermore, lhe presence ofWBCs mar compromise lhe storage conditions of blood components. [4] [5] [6] [7] WBC reduction ofred cell (RBC)concentrates of70 to 90 percent can be achieved by removing lhe buffy coat (BC),and it is low enough to diminish febrile nonhemolytic transfusion reactions.8WBCreduction to fewerthan5 x 106perRBC concentrate or platelet concentrate is thought to be sufficient to preveni alloimmunization,9-14 although lhe precise number ofresidual WBCs atwhich alI lhe above-mentioned deleterious effects would be abolished is difficult to establish: it could in fact be much lower than 5 x 106WBCs per unit.
RBC filters have been optimized in various ways to achieve lhe highest rale ofWBC removal, combined with lhe lowest loss ofRBCs. The first filters were made of cotton woal or cellulose acetate and had a large volume, which made it necessaryto rinse lhe filter.15Currently, filters are composed oflayers ofpolyester or polyurethane and have small deadspace volumes. Filtration has become a single-step procedure, with WBC reduction up to 510glO. 16, 17 The aim ofthis studywas to compare lhe WBC-reduction efficiency of six commercially available filters for RBCs. Before filtration, lhe BC-depleted RBC concentrates were pooled and then divided in lhe original bags to circumvent donor-dependent differences. For three filters, lhe filtratian was performed at both roam temperature (RT) and 4°C, which allowed an analysis of lhe influence of temperature an filtration efficiency. Our requirements for WBC-reduced RBCs are WBCs <5 x 106,platelets <15 x 109,total volume >225 rol, RBC volume> 119 rol, and total hemoglobin >38 g per unit.
with 63 mL of CPD and in one satellite bag with 100 mL of saline-adenine-glucose-mannitol as additive for the RBCs (Biopack-Compoflex, NPBI, Emmer-Compascuum, the Netherlands).AlI whole-blood donations were cooled to 20 to 24°C under 1,4 butane-diol plates, as previously described. 18 The following dar, between 18 and 24 hours after blood collection, the whole blood was centrifuged for 10 minutes at 2960 x g in a centrifuge (J6MI, Beckman, PaIo Alto, CA) at RT.Whole blood was then separated into plasma, BC, and BC-depleted RBC concentrates, using an automated blood component separation device (Compomat G4, NPBI).
Pooling and dividing of lhe RBCs
To exclude donor-dependent differences, for each experiment, 9 BC-depleted RBC concentrates, with identicalABO and Rh blood groups, were pooled and subsequently divided into the original bags.A3-L pool bag (NPBI) was connected with the appropriate tubing bythe use ofnine leads. auto each lead, an RBC bag was welded by using a sterile connection device (SCD-20l A, Temmo, Tokyo, Japan). The contents of the RBC bags were transferred to the pool bago The RBC pool was mixed thoroughly for at least 1 minute, and the contents were returned to the original RBC bags. Care was taken that the bags were filled uniformly, and the pool bag was mixed regularly to prevent sedimentation of the cells. After completion of this process, the bags were disconnected by heat-sealing, and the units were weighed.
A 150-mL transfer bag (Biopack-Compoflex, P4160, NPBI) was welded to each of the RBC bags. After thorough mixing, a sample of approximately 10 mL was obtained fiom each of the 9 units for in vitro analysis.
Filtration of lhe BC-depleted RBC concentrates
All steps afilie filtration protocol were performed according to the instructions of the manufacturers. The following filters were used: Leucoflex LCG1 (FEM 4007 A, lot no. 2908 97A23; MacoPharma, Tourcoing, France), Cellselect FR (B3118, lotno. 96K29; NPBI), CellselectOptimaPlus (B2145, lot no. 9507050707; NPBI), BPF4 (BPF4BBS, lot no. 96H23LO1;PalI, Newquay, UK), Sepacell (RZ-200Bl, lotnos. 259 TXF and 661 U2A; Asahi Medical Co., Tokyo, Japan: distributed by Baxter, Utrecht, the Netherlands), and Imugard III-RC 4P (TF*IRI602ES, lot no. 961O0lBl; Terumo, Tokyo, Japan). The filters are IDade oflayers ofpolyester, exceptfor the Imugard filter, which is IDade of polyurethane. Every filter possessed an air bypass.
All filters were supplied by the manufacturers. First, an RBC bag was welded to each of the filters. RBCs to be filtered at 4°C were then placed under a cooled (2-6°C) butane plate at 2 to 6°C. Units were cooled to 4°C within 2 hours, as confirrned by temperature measurements (Escort, Auckland, NZ). Filtration afilie cooled units was performed in a refrigerated roam (2-6°C).
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The BPF4 and the Sepacell had to be filled by squeezing of the RBC bago AlI other filters were filled spontaneously. All filtrations were performed by hanging the RBCbag approximately 1 m above the collection bago Air was expelled from the collection bag when the RBC bag was empty. Air was returned from the collection bag to the RBC bag through the air bypass, and it was used to remove the last blood fiom the filter. The air bypass possessed a one-way valve to prevent blood flow through the bypass. Filtration was terminated when no blood was visible on the entrance side afilie filter (exceptwith the Optima Plus filter, which did not have transparent housing: in it, filtration was terminated when no blood flow from the filter to the collection bag was visible).
After filtration, the weight of the filtered units was measured. A total of 12 sets of experiments was performed.
WBC concentration in BC-depleted RBC concentrates afiar quick cooling and rewarming
To investigate whether the quick-cooling procedure had a deleterious effect on WBCs, 9 BC-depleted RBC concentrates were quickly cooled and rewarmed. With a syringe, 5-mL samples were taken before cooling, after the bags were placed under a cooled butane plate for 2 hours, and again afterrewarmingfor 16hours. The sampleswere analyzed within 10 minutes after drawing.
In vitro measurements
The volume of the RBCs was calculated by dividing the net weight of the content of the bag by the specific gravity of the units (1.070 g/rnL at 60% hematocrit). Samples fiom the filtered RBCs were obtained by cutting the tubing after thorough mixing. Hematocrit values; RBC, WBC, and platelet counts; and hemoglobin content were determined with an analyzer (CA570, Medonic, Bromma, Sweden). The volume of RBCs was calculated fiom the hematocrit and the total volume of the unit.
WBCs in the filtered RBCs were counted in a Nageotte hemocytometer, usinga l-in-5 dilutionin alysingsolution (Leucoplate, Labo International, Maarssen, the Netherlands); the whole chamber (50 J.1L) was counted. Absolute numbers ofRBCs, WBCs, and platelets per unitwere calculated fiom the volume and the cell counts.
Statistical analysis
AlI results were entered into a computer, and, by using a software program (lnstat version 2.04, GraphPad Software, San Diego, CA) for statistical analysis, the data were compared. We used the repeated-measures ANOVA for paired I samples (except when stated otherwise) and then used a I
Tukey-Kramer multiple-comparisons test to determine the difference between individual filters.Effectivepairing ofthe I samples was determined as a significant variation among means; p<0.05 was considered significant.
Comp05ition 01 pooled, divided BC-depleted RBC concentrate5
Pairing of the BC-depleted RBC concentrates was highly effective (p<O.OOOl), and no significant differences between units could be detected for any of the measures. The results ofthe RBCs before filtration are represented in Table 1 . AlI units conform to our usual quality contraI standards for RBCs, although the volume was smalIer than that of regular RBCs, because of pooling and sampling. The number ofplatelets present in the BC-depleted RBC concentrates is already below the limit for filtered RBCs, <15 x 109per unit.
WBC and platelet removal
AlI tested filters were able to reduce the WBC number to below 5 x 106,as shown in Table 2 . The Leucoflex praduced filtered RBCs with the lowest number of WBCs per unit. Although slightly higher numbers of residual WBCs were obtained by filtration with the SepacelI at 4°C, the Imugard at RT, and the BPF4 at 4°C, the differences were not significant.
For filters tested both at RT and 4°C, filtration at RT was less efficient; the number of residual WBCs was at least twice that with filtration at 4oCO The CelIselect FR praduced filtered RBCs with 1.79:t 0.69 x 106at RT versus 0.86:t 0.37 x 106at4°C, p<O.OO1. Forthe BPF4 and the SepacelI, the differences caused by the filtration temperature were even more pranounced.
The performance of the examined filters was further specified according to the numbers ofWBCs in the filtered RBCs: in Table 2 , the number offiltered RBCs with <1 x 106 and <0.5 x 106WBCs per unit is shown. The Leucoflex gave the best performance with alI filtered RBCs containing <0.5 x 106WBCs per unit.
As noted earlier, the number ofplatelets before filtration was already below our specifications for filtered RBCs, which should be taken into account in the interpretation of the folIowing observation. Platelet remova! was shown to be independent of filtration temperature (see Table 2 ): it averaged 25 percent for alI filters tested, except for the BPF4, which removed only 10 percent of the platelets originalIy present (p<0.05).
Volume and hemoglobin 1055 after filtration
During filtration, a volume of blood is lost in the housing of the filter. Because of the large housing of the Optima Plus, 10 out of 12 filtered RBC units had a total volume below the specifications (i.e., <225mL). The Leucoflexpraduced 6 filtered RBC units with a low volume. AlI other units conform to the specifications. Except for the Optima Plus, in which the hematocrit afieI filtration was lower than that before filtration (p =0.01, paired ttest; see Table 3 ), RBCs were not specifically retained by the filters. Therefore, volume loss strongly correlated with the number of RBCs lost during filtration (linear regression, r = 0.96): the largerthe dead-spacevolume afilie filter, the more RBCs and hemoglobin lost. Filtration at 4°C or RT did not significantly affect the volume lost with the same filter. AlIfilters produced filtered RBCs with various volumes (p<O.OOIfor alI filters, except when stated otherwise in the legend ofTable 3), and, consequently, the number and volume ofRBCs and ofthe hemoglobin lost during filtration were algo significantly different.
The BPF4 was the smalIest filter tested, with a volume 10ssofonly22:t 1mL, reflected as anRBCloss ofO.14:t 0.02 x 1012(13:t 2 mL) cells and a hemoglobin loss of 4.3:t 1.1 g.
The Optima Plus, the largest filter in these experiments, yielded 3 filtered REC units with a volume of RECs below our specifications (Le., <119 mL), while 5 filtered REC units had a low «38 g) hemoglobin contento Leucoflex, the second largest filter, produced 1 unit with a low hemoglobin content. AlI other units conform to our specifications.
Filtration time
The Sepacell and the BPF4 were filled bysqueezingthe REC bago Filling occurred within 15 seconds at RT and took slightly longer at 4°C, as shown in Table 4 . AlI other filters were filled spontaneously, taking from about 38 seconds for the Imugard up to more than 7 minutes for the Optima Plus. Filling at 4°C took longer to complete than that at RT (p<O.OOOI, paired t test). The quickest filtration was achieved with the BPF4 at RT, in an average of 6 minutes.
Influence of cooling and warming on WBCs in BCdepleted RBC concentrates To exclude the possibility that WBCswould fragment because of the quick cooling, resulting in an apparently low WBC content afieI cooling, we performed WBC counts befale and afieI cooling and afieI rewarming. Before cooling, the mean WBC concentration in 9 BC-depleted REC concentrates was 1.9 :t 1.3 x 106 per mL. Afier cooling to 4°C, the number ofWBCs was slightly but significantly higher: 2.0:t 1.3 X106per mL (p = 0.02,paired ttest). Afierrewarming, the WBC concentration was again 1.9:t 1.3 x 106per mL. We presume that the slightly higher number ofWBCs afier cooling is due to the counting of platelet aggregates as WBCs by the cell analyzer. From these data, it can be concluded that quick cooling did not have a diminishing effect on the WBC contento
DISCUSSION
In this study, we evaluated the performance ofsixWBC-reduction filters for BC-depleted RBC concentrates. AlItested filters could remove WBCs to a leveI below the current upper limit for WBC reduction of 5 x 106 per unit. The best results were obtained with Leucoflex, BPF4, Sepacell (alI three at4°C), andImugard (atRT) filters. The performance at RT of Imugard, a polyurethane filter, was as good as that afilie polyester filters at 4°C. We found that, with polyester filters, filtration at 4°C provided the best results. When 2 identical units were filtered at both RT and 4°C, the number of residual WBCs at RT was at least double the number found at 4°C.
In polyester filters, capture ofWBCs is caused by three mechanisms: 1) mechanical sieving; 2) direct adhesion of WBCs to the filter material; and 3) indirect adhesion of WBCs to adhering platelets.19 Filtration ofWBCs is a combined result of these mechanisms, which are in addition tempera fure -depen den t.
As shown by Steneker et al.,19 activated platelets and platelets with pseudopodia piar a major role in indirect granulocyte adhesion, whereas Iymphocytes are mainly captured by mechanical sieving. Because the WBCs present Further, we conjecture that direct and indirect adheSiDOoccurs mainlyatRT, when lhe membranefluidityofthe cells enables direct adherence. Membrane fluidity permits lhe WBCs to pass through pores much smaller than lhe actual cell diameter, and, therefore, sieving will play a rei ativelysmalI role in lhe filtration process at RT. In contrast, we hypothesize that, at 4°C, mechanical sieving will be lhe most prominent mechanism of WBC removal, because membrane rigidity prevents cells from passing through small pores. In our experiments and those of others/, [23] [24] [25] filtration at RT was less efficient than filtration at 4°C.We believe that this was true because lhe adhesion of WBCs was not able to compensate for lhe loss of mechanieal sieving. Filtration at 4°C has lhe consequence that, according to current Good Manufacturing Practices, lhe units must be cooled in a controlled manDeI, and lhe filtration must be performed in a refrigerated roam to satisfy lhe striet temperature control. This requirement may, however, have some logistieal disadvantages.
The better performance at RT ofthe IglUgard(polyurethane filter) than of lhe polyester filters may be due to lhe filtrationmaterial:ithas been statedthat lhe poresof polyurethane can be IDade so small that WBCs are retained, even at RT.26In that case, mechanieal sieving is lhe most significant filtration mechanism; adhesion to lhe filter material plays an insignifieant role. [26] [27] [28] Another possible contribution to lhe filtration performance may be lhe flow rate.27,28 At 4°C, blood viscosity is WBC-REDUCTION FILTERS higher, resulting in a decreased flow Iate, which may enhance lhe probability of platelet and WBCcapture in lhe filter material. A study using bedside filtration showed that filtration at4°C gavebetterWBC reduction than thatatRT, even when lhe flow rale was equal for both25; this suggested that olheI temperature-dependent mechanisms, such as sieving, are present.
The age ofthe RBCs at lhe time offiltration is an additional factor that should be considered. In our blood bank, RBCs are routinely filtered within 24 hours afieI phlebotomy. Our consideration is that WBCs deteriorate quickly afieI phlebotomy,6,29 and, because polyester filters do not adequately remove WBC fragments,30 HLA-bearing parlides may stm be present in lhe filtered RBCs, although no intact WBCs can be counted. As hypothesized by Sintnicolaas et al., 13secondary HLA alIoimmunization may stm occur, because afilie presence ofmicropartides. However, to address this possibility, further in vitro and in vivo studies should be performed.
The current standard for WBC-reduced components is less than 5 x 106WBCs per unit, but lhe Council of Europe recently recommended that WBC-reduced blood components should not contain more than 1 x 106WBCs per unit.
OnlyLeucoflex, BPF4,Sepacell (alIat4°C), and Imugard (at RT) conform to this more stringent demand for alI tested units.
We condude that alI filters conform to lhe current standards for WBC reduction. For routine preparation ofWBCreduced RBCs, lhe composition, temperature, and age of lhe RBCs and lhe logistic preferences should be taken into account in lhe final choiee of a filter. Moreover, it is of great importance to validate lhe chosen filter under routine conditions before implementation.
